Hormonal When the Endocrine System Loses Its Balance

Hormones are the body’s slow signaling network — and one of the first systems to misfire when stress, inflammation, and aging accumulate. Replacement therapy treats the symptoms by topping up what’s missing. Regenerative medicine asks whether the underlying endocrine tissue itself can be supported back toward better function.

Hormonal dysregulation in plain terms

By Jed Ryan, Founder and CEO · Reviewed by Adas Darinskas, PhD, Chief Science Officer · Published · Last reviewed

The endocrine system — the network of glands that produce and regulate hormones — runs on feedback loops that depend on healthy tissue at every node. The HPA axis (hypothalamus-pituitary-adrenal) governs stress response. The HPG axis (hypothalamus-pituitary-gonadal) governs sex hormones. The thyroid governs metabolic rate. When these systems falter, the patient experience is rarely just “low hormone” — it’s fatigue, brain fog, weight gain, mood shifts, sleep disruption, and slowed recovery, all interlinked.

We work with the following in this cluster:

Menopause Andropause Thyroid dysfunction Adrenal fatigue HPA axis dysregulation Metabolic syndrome Insulin resistance Sex-hormone decline

Hormonal conditions look very different on a lab panel, but they share enough underlying biology that the regenerative approach is broadly the same: support the tissue that produces and responds to hormones, restore the signaling that’s broken down, and reduce the inflammation that blunts receptor sensitivity.

Four systems behind endocrine decline

Whether the entry point is perimenopause, low testosterone, thyroid dysfunction, or adrenal exhaustion, the same four systems tend to be in trouble underneath the lab numbers.

  • HPA / HPG axis dysregulation. Chronic stress, sleep disruption, and inflammation desensitize the feedback loops between hypothalamus, pituitary, and end-organ glands. Output drops; downstream effects compound.
  • Mitochondrial decline in endocrine cells. Hormone synthesis is metabolically expensive. Adrenal cortex, gonadal tissue, and thyroid cells all depend on dense mitochondrial networks. When mitochondrial function falls, hormone production falls with it — before any cell loss is detectable.
  • Chronic inflammation impairing hormone signaling. Inflammatory cytokines reduce hormone receptor expression and sensitivity. The body can have adequate hormone levels but fail to respond to them — a pattern often missed when only serum hormones are measured.
  • Insulin resistance and metabolic dysfunction. Insulin and the hormones around it (cortisol, leptin, adiponectin) form a tightly coupled system. Once insulin signaling fails, sex hormones, thyroid function, and HPA balance follow.

Bioidentical hormone replacement addresses the first system effectively but does nothing for the underlying tissue health, mitochondrial capacity, or receptor sensitivity. Regenerative protocols target the substrate hormone replacement is layered on top of.

What advanced cell and signaling therapies actually do in endocrine dysfunction

Endocrine tissue is metabolically demanding, vascularly intricate, and slow to repair on its own. Three primary mechanisms do most of the work in regenerative protocols.

  • Cellular repair of endocrine tissues. Mesenchymal stem cells and the exosomes they secrete home to inflamed and degenerating tissue, including endocrine glands. Their paracrine output supports surviving cells, modulates the local immune environment, and stimulates tissue-resident progenitor populations.
  • Mitochondrial support. MSCs can transfer functional mitochondria to stressed cells via tunneling nanotubes and extracellular vesicles. In endocrine tissue, where hormone synthesis depends on mitochondrial capacity, this transfer translates directly into improved function.
  • Anti-inflammatory restoration of receptor sensitivity. Reducing chronic inflammation re-sensitizes hormone receptors. Patients often report symptom improvement that runs ahead of any change in measured hormone levels — the same hormones, finally being heard.
  • Targeted peptide signaling. Specific peptides extend the cellular work in ways no single hormone replacement can: metabolic peptides (Tesofensine, Retatrutide, MOTS-c) restore insulin sensitivity and metabolic balance; HPG-axis peptides (Kisspeptin-10, Gonadorelin) support the body’s own hormone production rather than replacing it.

The framing is mechanistic: regenerative medicine targets the cellular substrate hormones are produced from and act on. Whether moving those signals improves a specific patient’s symptoms is the clinical question — answered case by case, with full lab follow-up.

What we use, and why we use it

Each protocol is designed individually by Dr. Adas Darinskas based on the specific endocrine pattern, lab profile, and treatment history. The four building blocks below are the ones most often deployed for hormonal cases.

Cellular Therapy

Next-generation MSCs

An advanced class of mesenchymal stem cells with a stress-enduring property. Delivered systemically by IV, they support endocrine tissue through paracrine signaling and mitochondrial transfer. Particularly relevant in adrenal, thyroid, and gonadal dysfunction where the underlying tissue is depleted rather than absent.

Learn more
Metabolic Peptides

Tesofensine, Retatrutide, MOTS-c

A defined stack targeting metabolic dysregulation specifically. Tesofensine and Retatrutide address insulin resistance and weight regulation through receptor pathways. MOTS-c is a mitochondrial-derived peptide that improves insulin sensitivity and metabolic flexibility from the cellular level up. Run as defined-duration cycles.

Learn more
HPG-Axis Peptides

Kisspeptin-10, Gonadorelin

Peptides that work upstream of sex hormones — supporting the hypothalamic-pituitary-gonadal signaling that governs the body’s own production. The goal is restoration of endogenous function rather than long-term replacement. Particularly useful in andropause, perimenopausal transition, and post-cycle support.

Learn more
Metabolic Support

IV nutrient and NAD+ protocols

NAD+ infusions support the mitochondrial cofactor pool that endocrine tissue depends on. Vitamin C, glutathione, and amino-acid IVs support adrenal and thyroid metabolism. Often layered into the days surrounding cellular therapy.

Learn more

For most hormonal cases the protocol layers these — cellular therapy supporting underlying tissue, metabolic and HPG peptides addressing specific axes, and metabolic IVs underwriting the bioenergetic load. Lab follow-up at defined intervals tracks response.

What does the research say?

Strong Craft Regen maintains a continuously updated repository of peer-reviewed research on regenerative medicine — the studies, mechanisms, and ongoing investigations that inform every protocol we coordinate.

Explore the research →

Take the first step today

Book a free discovery call. We’ll listen first, then walk through whether a regenerative protocol is the right next move for your case.